SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?


To: Jim Roof who wrote (816)4/1/1998 8:42:00 PM
From: Anaxagoras  Read Replies (2) | Respond to of 1432
 
I just happened across a post on the ZONA thread that gives a little additional info on the approval time frame for "standard" drugs, which I assume Hextend will be classified as. According to this info, it is possible that Hextend could be approved in as little as ten months. I had forgotten about this.

Message 3921351

Anaxagoras